BI 3804379

BI-3804379 · Boehringer Ingelheim

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BI 3804379, covering 2026-03-31 to 2026-03-31. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Test How Well Different Doses of BI 3804379 Are Tolerated by Healthy People [Phase 1]